P-180A phase 2 study of capecitabine plus oxaliplatin...

P-180A phase 2 study of capecitabine plus oxaliplatin therapy (XELOX) for patients with inoperable/advanced gastric cancer who were resistant/intolerable to fluoropyrimidine, CDDP, taxane, and CPT-11 (OGSG1403)

Kawada, J, Sugimoto, N, Hirokazu, T, Ueda, S, Murakami, K, Nishikawa, K, Kurokawa, Y, Fujitani, K, Kawakami, H, Sakai, D, Shimokawa, T, Satoh, T
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz155.179
Date:
July, 2019
File:
PDF, 74 KB
2019
Conversion to is in progress
Conversion to is failed